Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its stereochemistry enables selective binding to specific enzyme active sites, improving drug efficacy and reducing off-target effects. Commonly employed in the preparation of small-molecule drugs aimed at treating solid tumors and hematological malignancies. Also utilized in medicinal chemistry research for structure-activity relationship (SAR) studies due to its rigid cyclopropyl and halogenated aryl moieties, which enhance metabolic stability and membrane permeability.